- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03254914
Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study
August 17, 2017 updated by: Boryung Pharmaceutical Co., Ltd
A Multi-center, Cluster-randomized, Prospective, Observational Study
The purpose of this study is to evaluate the effect of home blood pressure monitoring on controlling blood pressure and correlation between home blood pressure and clinic blood pressure in hypertensive patients receiving two or more concomitant antihypertensive agents including fimasartan
Study Overview
Detailed Description
A multi-center, cluster-randomized, prospective, observational study
Study Type
Observational
Enrollment (Anticipated)
4320
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hyung-jin Jung, MD
- Phone Number: 82-2-708-8233
- Email: hjjung@boryung.co.kr
Study Locations
-
-
-
Seoul, Korea, Republic of
- Recruiting
- Seoul National University Hospital
-
Contact:
- Hae-young Lee, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Hypertensive patients
Description
Inclusion Criteria:
- Subjects who voluntarily signed informed consent for participating in this clinical study
- Male and female over the age of 19
- Hypertensive patients receiving two or more concomitant anti-hypertensive agents including fimasartan
Exclusion Criteria:
- Renal dialysis patients.
- Diabetic nephropathy patients taking angiotensin-converting enzyme inhibitor.
- Severe renal disorder
- Subjects with hereditary disorders of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
- Medical history with hypersensitivity to Fimasartan
- Pregnant women or lactating female.
- Participate in another clinical trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Control Site
Measure Clinic Blood Pressure
|
|
Test Site
Measure Clinic Blood Pressure and Home Blood Pressure
|
Measure Home Blood Pressure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of reaching target blood pressure
Time Frame: 12 weeks after treatment
|
Rate of reaching target blood pressure after treatment for 12 weeks
|
12 weeks after treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hae-young Lee, MD, Seoul National Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 9, 2017
Primary Completion (Anticipated)
February 28, 2019
Study Completion (Anticipated)
September 30, 2019
Study Registration Dates
First Submitted
August 17, 2017
First Submitted That Met QC Criteria
August 17, 2017
First Posted (Actual)
August 21, 2017
Study Record Updates
Last Update Posted (Actual)
August 21, 2017
Last Update Submitted That Met QC Criteria
August 17, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BR-FMS-OS-403
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
Clinical Trials on Home Blood Pressure
-
Oslo University HospitalRecruitingCardiovascular Diseases | Hypertension | Kidney Transplant; ComplicationsNorway
-
Meir Medical CenterNovartis PharmaceuticalsTerminatedBlood Pressure, HighIsrael
-
Queen's UniversityHeart and Stroke Foundation of OntarioCompleted
-
University of Maryland, BaltimoreTerminated
-
Erling Bjerregaard PedersenCompleted
-
Prisma Health-UpstateMedical University of South Carolina; South Carolina Telehealth Alliance; Bab...CompletedPreeclampsia | HELLP Syndrome | Gestational Hypertension | Chronic Hypertension With Pre-Eclampsia Complicating ChildbirthUnited States
-
Universidad Peruana Cayetano HerediaCompleted
-
Jichi Medical UniversityCompleted
-
Aristotle University Of ThessalonikiRecruitingHypertension | Chronic Kidney DiseasesGreece